PCA
LLY icon

Pallas Capital Advisors’s Eli Lilly LLY Stock Holding History

Pallas Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
9,795
-1
-0% -$1.02K 0.36% 50
2026
Q1 		$9.01M Sell
9,796
-7,543
-44% -$7.65M 0.34% 59
2025
Q4 		$18.6M Sell
17,339
-588
-3% -$562K 0.62% 33
2025
Q3 		$13.7M Buy
17,927
+240
+1% +$179K 0.5% 41
2025
Q2 		$13.8M Sell
17,687
-2,121
-11% -$1.65M 0.53% 37
2025
Q1 		$16.4M Buy
19,808
+2,659
+16% +$2.21M 0.68% 26
2024
Q4 		$13.2M Buy
17,149
+463
+3% +$383K 0.57% 35
2024
Q3 		$14.9M Buy
16,686
+1,319
+9% +$1.19M 0.64% 29
2024
Q2 		$13M Buy
15,367
+562
+4% +$450K 0.59% 32
2024
Q1 		$11.5M Sell
14,805
-4,636
-24% -$3.3M 0.48% 33
2023
Q4 		$11.3M Buy
19,441
+453
+2% +$264K 0.6% 30
2023
Q3 		$10.7M Buy
18,988
+1,692
+10% +$872K 0.65% 27
2023
Q2 		$7.73M Buy
17,296
+14,101
+441% +$5.91M 0.35% 41
2023
Q1 		$1.22M Buy
3,195
+671
+27% +$226K 0.11% 128
2022
Q4 		$873K Sell
2,524
-383
-13% -$136K 0.09% 161
2022
Q3 		$1.05M Sell
2,907
-236
-8% -$74.8K 0.12% 135
2022
Q2 		$1.03M Sell
3,143
-11,538
-79% -$3.46M 0.14% 116
2022
Q1 		$4.43M Sell
14,681
-12,876
-47% -$3.31M 0.57% 52
2021
Q4 		$6.7M Buy
27,557
+2,012
+8% +$510K 0.82% 32
2021
Q3 		$6.8M Buy
25,545
+4,081
+19% +$1.01M 0.75% 26
2021
Q2 		$5.63M Buy
21,464
+3,079
+17% +$618K 0.79% 28
2021
Q1 		$3.58M Buy
+18,385
New +$3.6M 0.8% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pallas Capital Advisors's LLY Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Eli Lilly (LLY) stake by 0.01% in Q2 2026, selling an estimated $1.02K and leaving 9,795 shares worth $11.7M. The position accounts for 0.36% of the portfolio, ranked #50.

Pallas Capital Advisors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. The position peaked at $18.6M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pallas Capital Advisors held 9,795 shares of Eli Lilly worth $11.7M as of Q2 2026.
  • Pallas Capital Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.36% of Pallas Capital Advisors's portfolio in Q2 2026, its #50 holding.
  • Pallas Capital Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • Pallas Capital Advisors's Eli Lilly position peaked at $18.6M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.